Advancing the search for antibodies to treat Alzheimer’s disease
Two new studies illustrate that not all forms of amyloid-beta protein — the protein thought to initiate Alzheimer’s disease — play an equally menacing role in the progress of the disease. Using a new way of preparing and extracting the protein as well as a new technique to search for promising drug candidates, researchers have highlighted the importance of testing and targeting different forms of amyloid-beta.
Original source: https://www.sciencedaily.com/releases/2018/07/180730120402.htm
